COMP <GO>
EHC vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Encompass Health Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: EHC 3
— MRK 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $135.90 (+3.35%) • MKT CAP: $12.97B
balance-sheet
3.47
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EHC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EHC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.80% | 20.70% | -6.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 15.3x | +0.50 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 2.92% | 3.42% | -0.50 | MRK | /fcf-yield <GO> |
| Operating Margin | 11.60% | 34.30% | -22.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | 9.50% | 28.10% | -18.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 10.50% | 1.30% | +9.20 | EHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.55% | 2.26% | -1.71 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.47 | 5.19 | -1.72 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | EHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.2 | 56.9 | +12.37 | EHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.92 | -0.02 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.3x | 18.4x | +2.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.97B | $361.02B | -$348.05B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EHC REV | MRK REV | EHC GROSS % | MRK GROSS % | EHC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $65.01B | 44.0% | 74.8% | $367.1M | $12.36B |
| FY 2024 | $5.37B | $64.17B | 44.0% | 76.3% | $268.6M | $18.10B |
| FY 2023 | $4.80B | $60.12B | 44.0% | 44.0% | $178.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EHC // BETA 0.90
MRK // BETA 0.92